ClinicalTrials.gov
public full text
Public Domain
Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis
The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Presepsin in the Diagnosis of Sepsis in Critically Ill Patients#994351
- Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis#1032194
- The Study of NT-proBNP Combined With HS-cTnT in Evaluating the Prognosis of Sepsis#1047244
- Clinical Criteria for a Pathogen in Term Newborn Suspected of Neonatal Sepsis#865874
- Proadrenomedullin and Copeptin in Patients With Septic Shock#980501
Record · ID 1197669
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive